Related Experiment Videos
Management of bleeding gastroduodenal ulcers
Stig Borbjerg Laursen1, Henrik Stig Jørgensen, Ove B Schaffalitzky de Muckadell
1Department of Gastroenterology S, Odense University Hospital, Odense C, Denmark. Sdm@OUH.regionsyddanmark.dk
Danish Medical Journal
|July 5, 2012
Summary
Early resuscitation and prompt endoscopy within 24 hours are key for managing bleeding gastroduodenal ulcers. High-risk patients benefit from intravenous high-dose proton pump inhibitor (PPI) therapy and a 3-day hospital stay post-hemostasis.
Area of Science:
- Gastroenterology
- Clinical Medicine
- Evidence-Based Medicine
Background:
- Gastroduodenal ulcers are a significant cause of gastrointestinal bleeding.
- Effective management strategies are crucial to reduce morbidity and mortality.
Purpose of the Study:
- To provide evidence-based guidelines for the management of bleeding gastroduodenal ulcers.
- To optimize patient outcomes through timely and appropriate interventions.
Main Methods:
- Development of a guideline by Danish experts based on published studies up to March 2011.
- Grading of evidence quality and strength of recommendations.
- Approval by the Danish Society of Gastroenterology and Hepatology.
Main Results:
- Early resuscitation and endoscopy within 24 hours reduce complications and hospital stay.
- Endoscopic hemostasis is recommended for high-risk lesions using clips, thermocoagulation, or epinephrine injection (not as monotherapy).
- Intravenous high-dose proton pump inhibitor (PPI) therapy for 72 hours post-hemostasis decreases rebleeding and mortality in high-risk patients.
Conclusions:
- Prompt endoscopic intervention and appropriate medical management, including PPI therapy, are vital for bleeding gastroduodenal ulcers.
- Careful consideration of cardiovascular versus gastrointestinal risks is necessary when restarting antiplatelet therapy (e.g., acetylsalicylic acid [ASA]).
- Prophylactic proton pump inhibitor (PPI) treatment is recommended for patients on ASA or nonsteroidal anti-inflammatory drugs (NSAIDs).
Related Concept Videos
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
01:23Gastritis III: Clinical Manifestations and Management
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:25Peptic Ulcer Disease III: Clinical Manifestations and Complications
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...